Company Zai Lab Limited

ZLAB

US98887Q1040

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-22 pm EDT			5-day change	1st Jan Change
18.48 ^USD	+1.65%		+4.23%	+4.76%

Jun. 16	Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug	MT
Jun. 10	Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	MT

Business description: Zai Lab Limited

Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Number of employees: 1,784

Sales by Activity: Zai Lab Limited

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Biotechnology	144M	215M	267M	399M	460M

See all business segments

Geographical breakdown of sales: Zai Lab Limited

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
People's Republic of China (PRC)	144M	-	-	399M	460M

See all geographic segments

Executive Committee: Zai Lab Limited

Manager	Title	Age	Since
Ying Du CEO	Chief Executive Officer	60	2014-03-31
Ya jing Chen DFI	Director of Finance/CFO	58	2023-07-06
Rafael Amado PSD	President	62	2022-11-30
Joshua Smiley PSD	President	56	2023-03-31
Robert Brown CTO	Chief Tech/Sci/R&D Officer	-	2023-08-31

See ZAI LAB LIMITED governance

Composition of the Board of Directors: Zai Lab Limited

Director	Title	Age	Since
Ying Du CHM	Chairman	60	2014-03-31
John Diekman BRD	Director/Board Member	82	2016-12-31
Peter Wirth BRD	Director/Board Member	74	2016-12-31
William David Lis BRD	Director/Board Member	61	2018-09-30
Lonnie Moulder BRD	Director/Board Member	68	2018-12-31
Scott Morrison BRD	Director/Board Member	68	2021-10-12
Richard Gaynor BRD	Director/Board Member	76	2021-11-18
Wing Yu Leung BRD	Director/Board Member	54	2014-07-31
Michel Vounatsos BRD	Director/Board Member	64	2023-01-06

Composition of the Board of Directors

Shareholders: Zai Lab Limited

Name	Stocks	%	Valuation
RTW Investments LP 5.797 %	6,574,032	5.797 %	116 M $
TCG Crossover Management LLC 5.214 %	5,913,075	5.214 %	105 M $
RA Capital Management LP 5.062 %	5,740,762	5.062 %	102 M $
RA Capital Management LP 5.032 %	5,707,262	5.032 %	101 M $
Frazier Life Sciences Management LP 1.677 %	1,902,320	1.677 %	34 M $

Name	Stocks	%	Valuation
Qiming Venture Partners Ltd. 4.31 %	48,883,643	4.31 %	87 M $
Wellington Management Co. LLP 4.242 %	48,112,590	4.242 %	85 M $
JANUS HENDERSON GROUP PLC 3.483 %	39,501,040	3.483 %	70 M $
Goldman Sachs International (Invt Mgmt) 3.122 %	35,411,264	3.122 %	63 M $
Goldman Sachs & Co. LLC (Private Banking) 2.094 %	23,744,447	2.094 %	42 M $

List of ZAI LAB LIMITED shareholders

Company details: Zai Lab Limited

Zai Lab Ltd.

899 Halei Road

201203, Shanghai

+86 21 6163 2588

http://www.zailaboratory.com

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZAI LAB LIMITED	+1.65%	+4.23%	-46.51%	-28.90%	2.04B
REGENERON PHARMACEUTICALS, INC.	+0.42%	-0.40%	+20.16%	-21.46%	62.05B
UCB	-0.84%	-4.48%	+57.21%	+196.38%	54.52B
SAMSUNG BIOLOGICS CO.,LTD.	-5.75%	+29.50%	+29.50%	+29.50%	41.55B
CSL LIMITED	+1.36%	+7.67%	-52.49%	-59.43%	39.06B
BIOGEN INC.	+1.59%	+0.54%	+57.20%	-32.06%	29.02B
MODERNA, INC.	-7.22%	+13.84%	+129.13%	-50.74%	25.38B
INCYTE CORPORATION	+5.54%	+1.65%	+51.42%	+67.44%	19.62B
INNOVENT BIOLOGICS, INC.	+0.33%	-1.05%	-4.18%	+148.28%	16.89B
SWEDISH ORPHAN BIOVITRUM AB	+1.04%	+2.25%	+63.17%	+111.01%	15.89B
Average	-0.19%	+2.33%	+30.46%	+36.00%	30.6B
Weighted average by Cap.	-0.68%	+1.16%	+33.76%	+37.89%